ナノ医薬品の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)

【英語タイトル】Global Nanopharmaceuticals Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

GlobalInfoResearchが出版した調査資料(GIR8104398)・商品コード:GIR8104398
・発行会社(調査会社):GlobalInfoResearch
・発行日:2018年8月15日
・ページ数:138
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:世界
・産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、ナノ医薬品の世界市場について調べ、まとめました。種類別セグメントは、リポソーム、高分子ミセル、固体脂質ナノ粒子、マイクロエマルションおよびナノエマルジョン、ナノ懸濁液等、用途別セグメントは、がんおよび腫瘍、自己免疫疾患、炎症、その他等に区分しました。ナノ医薬品の世界市場概観、メーカー動向、メーカー別ナノ医薬品シェア、市場規模推移、市場規模予測、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・ナノ医薬品の市場概観
・ナノ医薬品のメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・ナノ医薬品のメーカー別販売動向、市場シェア、市場集中度、競争動向
・ナノ医薬品の世界市場規模
・ナノ医薬品の北米市場分析(アメリカ、カナダ、メキシコ等)
・ナノ医薬品のアメリカ市場規模推移
・ナノ医薬品のカナダ市場規模推移
・ナノ医薬品のメキシコ市場規模推移
・ナノ医薬品のヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・ナノ医薬品のドイツ市場規模推移
・ナノ医薬品のイギリス市場規模推移
・ナノ医薬品のロシア市場規模推移
・ナノ医薬品のアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・ナノ医薬品の日本市場規模推移
・ナノ医薬品の中国市場規模推移
・ナノ医薬品の韓国市場規模推移
・ナノ医薬品のインド市場規模推移
・ナノ医薬品の東南アジア市場規模推移
・ナノ医薬品の南米市場分析(ブラジル、アルゼンチン等)
・ナノ医薬品の中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・ナノ医薬品の種類別分析/市場規模推移(リポソーム、高分子ミセル、固体脂質ナノ粒子、マイクロエマルションおよびナノエマルジョン、ナノ懸濁液)
・ナノ医薬品の用途別分析/市場規模推移(がんおよび腫瘍、自己免疫疾患、炎症、その他)
・ナノ医薬品の市場予測(地域別予測、種類別予測、用途別予測)
・ナノ医薬品の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Nanopharmaceuticals are colloidal particles of 10 to 1,000 nanometers (1 micron) in size. They are widely used in drug delivery. Nanopharmaceuticals are diverse both in their shape and composition and often offer an advantage as compared to their “bulk” counterparts primarily because of size.

There are two types of nanopharmaceuticals: (1) those where the therapeutic molecules are themselves the drug (i.e.,the therapeutic compound itself also functions as its own carrier); and (2) those where the therapeutic molecules are directly coupled (functionalized, entrapped, or coated) to a nanoparticle carrier.

Scope of the Report:
This report focuses on the Nanopharmaceuticals in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
USA is a huge market, and the total sum of the industry is more than 8756.7 million USD in 2015. At the same time, this industry continuously increases, with the development of global economy.
USA is the largest market of nanopharmaceuticals, which occupies 60.69 percent of global nanopharmaceuticals market share in 2014. It is followed by Europe, which has around 33.37 percent of the global total industry. Other main regions which take important part in this industry include Japan and China.
The relatively-mature technology is NanoCrystalsTM, DissCubes® and Nanopure®. The carrier includes nanospheres, nanocapsules, solid lipid nanoparticles, microemulsion, nanoliposome, magnetic nanoparticles, polymeric micelles, dendrimers, and inorganic nanometer carrier.
The worldwide market for Nanopharmaceuticals is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
Merck
Pfizer
Novartis
Abbott
GlaxoSmithKline
Roche
Sanofi
Eli Lilly
Astrazeneca
Johnson & Johnson
Celgene
Novavax
Stryker
Gilead Sciences
OSI Pharmaceuticals
Kadmon Pharmaceuticals
Samyang Biopharm
Mitsubishi Pharma
Kaken Pharmaceutical
Selecta Biosciences
Par Pharmaceutical
Cerulean Pharma
Navidea Biopharmaceuticals
Lummy

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Liposomes
Polymeric Micelles
Solid Lipid Nanoparticles
Microemulsion and Nnanoemulsion
Nanosuspension

Market Segment by Applications, can be divided into
Cancer and Tumor
Autoimmune Disorders
Inflammation
Others

There are 15 Chapters to deeply display the global Nanopharmaceuticals market.
Chapter 1, to describe Nanopharmaceuticals Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Nanopharmaceuticals, with sales, revenue, and price of Nanopharmaceuticals, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Nanopharmaceuticals, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Nanopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Nanopharmaceuticals sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Nanopharmaceuticals Introduction
1.2 Market Analysis by Type
1.2.1 Liposomes
1.2.2 Polymeric Micelles
1.2.3 Solid Lipid Nanoparticles
1.2.4 Microemulsion and Nnanoemulsion
1.2.5 Nanosuspension
1.3 Market Analysis by Applications
1.3.1 Cancer and Tumor
1.3.2 Autoimmune Disorders
1.3.3 Inflammation
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck
2.1.1 Business Overview
2.1.2 Nanopharmaceuticals Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Merck Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Pfizer
2.2.1 Business Overview
2.2.2 Nanopharmaceuticals Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Pfizer Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis
2.3.1 Business Overview
2.3.2 Nanopharmaceuticals Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Abbott
2.4.1 Business Overview
2.4.2 Nanopharmaceuticals Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Abbott Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 GlaxoSmithKline
2.5.1 Business Overview
2.5.2 Nanopharmaceuticals Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 GlaxoSmithKline Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Roche
2.6.1 Business Overview
2.6.2 Nanopharmaceuticals Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Roche Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Sanofi
2.7.1 Business Overview
2.7.2 Nanopharmaceuticals Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Sanofi Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Eli Lilly
2.8.1 Business Overview
2.8.2 Nanopharmaceuticals Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Eli Lilly Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Astrazeneca
2.9.1 Business Overview
2.9.2 Nanopharmaceuticals Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Astrazeneca Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Johnson & Johnson
2.10.1 Business Overview
2.10.2 Nanopharmaceuticals Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Johnson & Johnson Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Celgene
2.11.1 Business Overview
2.11.2 Nanopharmaceuticals Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Celgene Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Novavax
2.12.1 Business Overview
2.12.2 Nanopharmaceuticals Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Novavax Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Stryker
2.13.1 Business Overview
2.13.2 Nanopharmaceuticals Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Stryker Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Gilead Sciences
2.14.1 Business Overview
2.14.2 Nanopharmaceuticals Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Gilead Sciences Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 OSI Pharmaceuticals
2.15.1 Business Overview
2.15.2 Nanopharmaceuticals Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 OSI Pharmaceuticals Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Kadmon Pharmaceuticals
2.16.1 Business Overview
2.16.2 Nanopharmaceuticals Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Kadmon Pharmaceuticals Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Samyang Biopharm
2.17.1 Business Overview
2.17.2 Nanopharmaceuticals Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Samyang Biopharm Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Mitsubishi Pharma
2.18.1 Business Overview
2.18.2 Nanopharmaceuticals Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Mitsubishi Pharma Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Kaken Pharmaceutical
2.19.1 Business Overview
2.19.2 Nanopharmaceuticals Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Kaken Pharmaceutical Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 Selecta Biosciences
2.20.1 Business Overview
2.20.2 Nanopharmaceuticals Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Selecta Biosciences Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.21 Par Pharmaceutical
2.21.1 Business Overview
2.2.2 Nanopharmaceuticals Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Par Pharmaceutical Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.22 Cerulean Pharma
2.22.1 Business Overview
2.22.2 Nanopharmaceuticals Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Cerulean Pharma Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.23 Navidea Biopharmaceuticals
2.23.1 Business Overview
2.23.2 Nanopharmaceuticals Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 Navidea Biopharmaceuticals Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.24 Lummy
2.24.1 Business Overview
2.24.2 Nanopharmaceuticals Type and Applications
2.24.2.1 Product A
2.24.2.2 Product B
2.24.3 Lummy Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Nanopharmaceuticals Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Nanopharmaceuticals Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Nanopharmaceuticals Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Nanopharmaceuticals Manufacturer Market Share in 2017
3.3.2 Top 6 Nanopharmaceuticals Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Nanopharmaceuticals Market Analysis by Regions
4.1 Global Nanopharmaceuticals Sales, Revenue and Market Share by Regions
4.1.1 Global Nanopharmaceuticals Sales and Market Share by Regions (2013-2018)
4.1.2 Global Nanopharmaceuticals Revenue and Market Share by Regions (2013-2018)
4.2 North America Nanopharmaceuticals Sales and Growth Rate (2013-2018)
4.3 Europe Nanopharmaceuticals Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Nanopharmaceuticals Sales and Growth Rate (2013-2018)
4.5 South America Nanopharmaceuticals Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Nanopharmaceuticals Sales and Growth Rate (2013-2018)
5 North America Nanopharmaceuticals by Countries
5.1 North America Nanopharmaceuticals Sales, Revenue and Market Share by Countries
5.1.1 North America Nanopharmaceuticals Sales and Market Share by Countries (2013-2018)
5.1.2 North America Nanopharmaceuticals Revenue and Market Share by Countries (2013-2018)
5.2 United States Nanopharmaceuticals Sales and Growth Rate (2013-2018)
5.3 Canada Nanopharmaceuticals Sales and Growth Rate (2013-2018)
5.4 Mexico Nanopharmaceuticals Sales and Growth Rate (2013-2018)
6 Europe Nanopharmaceuticals by Countries
6.1 Europe Nanopharmaceuticals Sales, Revenue and Market Share by Countries
6.1.1 Europe Nanopharmaceuticals Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Nanopharmaceuticals Revenue and Market Share by Countries (2013-2018)
6.2 Germany Nanopharmaceuticals Sales and Growth Rate (2013-2018)
6.3 UK Nanopharmaceuticals Sales and Growth Rate (2013-2018)
6.4 France Nanopharmaceuticals Sales and Growth Rate (2013-2018)
6.5 Russia Nanopharmaceuticals Sales and Growth Rate (2013-2018)
6.6 Italy Nanopharmaceuticals Sales and Growth Rate (2013-2018)
7 Asia-Pacific Nanopharmaceuticals by Countries
7.1 Asia-Pacific Nanopharmaceuticals Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Nanopharmaceuticals Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Nanopharmaceuticals Revenue and Market Share by Countries (2013-2018)
7.2 China Nanopharmaceuticals Sales and Growth Rate (2013-2018)
7.3 Japan Nanopharmaceuticals Sales and Growth Rate (2013-2018)
7.4 Korea Nanopharmaceuticals Sales and Growth Rate (2013-2018)
7.5 India Nanopharmaceuticals Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Nanopharmaceuticals Sales and Growth Rate (2013-2018)
8 South America Nanopharmaceuticals by Countries
8.1 South America Nanopharmaceuticals Sales, Revenue and Market Share by Countries
8.1.1 South America Nanopharmaceuticals Sales and Market Share by Countries (2013-2018)
8.1.2 South America Nanopharmaceuticals Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Nanopharmaceuticals Sales and Growth Rate (2013-2018)
8.3 Argentina Nanopharmaceuticals Sales and Growth Rate (2013-2018)
8.4 Colombia Nanopharmaceuticals Sales and Growth Rate (2013-2018)
9 Middle East and Africa Nanopharmaceuticals by Countries
9.1 Middle East and Africa Nanopharmaceuticals Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Nanopharmaceuticals Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Nanopharmaceuticals Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Nanopharmaceuticals Sales and Growth Rate (2013-2018)
9.3 UAE Nanopharmaceuticals Sales and Growth Rate (2013-2018)
9.4 Egypt Nanopharmaceuticals Sales and Growth Rate (2013-2018)
9.5 Nigeria Nanopharmaceuticals Sales and Growth Rate (2013-2018)
9.6 South Africa Nanopharmaceuticals Sales and Growth Rate (2013-2018)
10 Global Nanopharmaceuticals Market Segment by Type
10.1 Global Nanopharmaceuticals Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Nanopharmaceuticals Sales and Market Share by Type (2013-2018)
10.1.2 Global Nanopharmaceuticals Revenue and Market Share by Type (2013-2018)
10.2 Liposomes Sales Growth and Price
10.2.1 Global Liposomes Sales Growth (2013-2018)
10.2.2 Global Liposomes Price (2013-2018)
10.3 Polymeric Micelles Sales Growth and Price
10.3.1 Global Polymeric Micelles Sales Growth (2013-2018)
10.3.2 Global Polymeric Micelles Price (2013-2018)
10.4 Solid Lipid Nanoparticles Sales Growth and Price
10.4.1 Global Solid Lipid Nanoparticles Sales Growth (2013-2018)
10.4.2 Global Solid Lipid Nanoparticles Price (2013-2018)
10.5 Microemulsion and Nnanoemulsion Sales Growth and Price
10.5.1 Global Microemulsion and Nnanoemulsion Sales Growth (2013-2018)
10.5.2 Global Microemulsion and Nnanoemulsion Price (2013-2018)
10.6 Nanosuspension Sales Growth and Price
10.6.1 Global Nanosuspension Sales Growth (2013-2018)
10.6.2 Global Nanosuspension Price (2013-2018)
11 Global Nanopharmaceuticals Market Segment by Application
11.1 Global Nanopharmaceuticals Sales Market Share by Application (2013-2018)
11.2 Cancer and Tumor Sales Growth (2013-2018)
11.3 Autoimmune Disorders Sales Growth (2013-2018)
11.4 Inflammation Sales Growth (2013-2018)
11.5 Others Sales Growth (2013-2018)
12 Nanopharmaceuticals Market Forecast (2018-2023)
12.1 Global Nanopharmaceuticals Sales, Revenue and Growth Rate (2018-2023)
12.2 Nanopharmaceuticals Market Forecast by Regions (2018-2023)
12.2.1 North America Nanopharmaceuticals Market Forecast (2018-2023)
12.2.2 Europe Nanopharmaceuticals Market Forecast (2018-2023)
12.2.3 Asia-Pacific Nanopharmaceuticals Market Forecast (2018-2023)
12.2.4 South America Nanopharmaceuticals Market Forecast (2018-2023)
12.2.5 Middle East and Africa Nanopharmaceuticals Market Forecast (2018-2023)
12.3 Nanopharmaceuticals Market Forecast by Type (2018-2023)
12.3.1 Global Nanopharmaceuticals Sales Forecast by Type (2018-2023)
12.3.2 Global Nanopharmaceuticals Market Share Forecast by Type (2018-2023)
12.4 Nanopharmaceuticals Market Forecast by Application (2018-2023)
12.4.1 Global Nanopharmaceuticals Sales Forecast by Application (2018-2023)
12.4.2 Global Nanopharmaceuticals Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Nanopharmaceuticals Picture
Table Product Specifications of Nanopharmaceuticals
Figure Global Sales Market Share of Nanopharmaceuticals by Types in 2017
Table Nanopharmaceuticals Types for Major Manufacturers
Figure Liposomes Picture
Figure Polymeric Micelles Picture
Figure Solid Lipid Nanoparticles Picture
Figure Microemulsion and Nnanoemulsion Picture
Figure Nanosuspension Picture
Figure Nanopharmaceuticals Sales Market Share by Applications in 2017
Figure Cancer and Tumor Picture
Figure Autoimmune Disorders Picture
Figure Inflammation Picture
Figure Others Picture
Figure United States Nanopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Nanopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Nanopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Nanopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Figure France Nanopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Figure UK Nanopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Nanopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Nanopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Figure China Nanopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Nanopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Nanopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Figure India Nanopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Nanopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Nanopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Nanopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Nanopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Nanopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Nanopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Nanopharmaceuticals Type and Applications
Table Merck Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Nanopharmaceuticals Type and Applications
Table Pfizer Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Nanopharmaceuticals Type and Applications
Table Novartis Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Nanopharmaceuticals Type and Applications
Table Abbott Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Nanopharmaceuticals Type and Applications
Table GlaxoSmithKline Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Nanopharmaceuticals Type and Applications
Table Roche Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Nanopharmaceuticals Type and Applications
Table Sanofi Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Nanopharmaceuticals Type and Applications
Table Eli Lilly Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Astrazeneca Basic Information, Manufacturing Base and Competitors
Table Astrazeneca Nanopharmaceuticals Type and Applications
Table Astrazeneca Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Nanopharmaceuticals Type and Applications
Table Johnson & Johnson Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Celgene Basic Information, Manufacturing Base and Competitors
Table Celgene Nanopharmaceuticals Type and Applications
Table Celgene Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novavax Basic Information, Manufacturing Base and Competitors
Table Novavax Nanopharmaceuticals Type and Applications
Table Novavax Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Stryker Basic Information, Manufacturing Base and Competitors
Table Stryker Nanopharmaceuticals Type and Applications
Table Stryker Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences Nanopharmaceuticals Type and Applications
Table Gilead Sciences Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table OSI Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table OSI Pharmaceuticals Nanopharmaceuticals Type and Applications
Table OSI Pharmaceuticals Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Kadmon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Kadmon Pharmaceuticals Nanopharmaceuticals Type and Applications
Table Kadmon Pharmaceuticals Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Samyang Biopharm Basic Information, Manufacturing Base and Competitors
Table Samyang Biopharm Nanopharmaceuticals Type and Applications
Table Samyang Biopharm Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Mitsubishi Pharma Basic Information, Manufacturing Base and Competitors
Table Mitsubishi Pharma Nanopharmaceuticals Type and Applications
Table Mitsubishi Pharma Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Kaken Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Kaken Pharmaceutical Nanopharmaceuticals Type and Applications
Table Kaken Pharmaceutical Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Selecta Biosciences Basic Information, Manufacturing Base and Competitors
Table Selecta Biosciences Nanopharmaceuticals Type and Applications
Table Selecta Biosciences Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Par Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Par Pharmaceutical Nanopharmaceuticals Type and Applications
Table Par Pharmaceutical Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Cerulean Pharma Basic Information, Manufacturing Base and Competitors
Table Cerulean Pharma Nanopharmaceuticals Type and Applications
Table Cerulean Pharma Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Navidea Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Navidea Biopharmaceuticals Nanopharmaceuticals Type and Applications
Table Navidea Biopharmaceuticals Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Lummy Basic Information, Manufacturing Base and Competitors
Table Lummy Nanopharmaceuticals Type and Applications
Table Lummy Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Nanopharmaceuticals Sales by Manufacturer (2016-2017)
Figure Global Nanopharmaceuticals Sales Market Share by Manufacturer in 2016
Figure Global Nanopharmaceuticals Sales Market Share by Manufacturer in 2017
Table Global Nanopharmaceuticals Revenue by Manufacturer (2016-2017)
Figure Global Nanopharmaceuticals Revenue Market Share by Manufacturer in 2016
Figure Global Nanopharmaceuticals Revenue Market Share by Manufacturer in 2017
Figure Top 3 Nanopharmaceuticals Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Nanopharmaceuticals Manufacturer (Revenue) Market Share in 2017
Figure Global Nanopharmaceuticals Sales and Growth Rate (2013-2018)
Figure Global Nanopharmaceuticals Revenue and Growth Rate (2013-2018)
Table Global Nanopharmaceuticals Sales by Regions (2013-2018)
Table Global Nanopharmaceuticals Sales Market Share by Regions (2013-2018)
Table Global Nanopharmaceuticals Revenue by Regions (2013-2018)
Figure Global Nanopharmaceuticals Revenue Market Share by Regions in 2013
Figure Global Nanopharmaceuticals Revenue Market Share by Regions in 2017
Figure North America Nanopharmaceuticals Sales and Growth Rate (2013-2018)
Figure Europe Nanopharmaceuticals Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Nanopharmaceuticals Sales and Growth Rate (2013-2018)
Figure South America Nanopharmaceuticals Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Nanopharmaceuticals Sales and Growth Rate (2013-2018)
Figure North America Nanopharmaceuticals Revenue and Growth Rate (2013-2018)
Table North America Nanopharmaceuticals Sales by Countries (2013-2018)
Table North America Nanopharmaceuticals Sales Market Share by Countries (2013-2018)
Figure North America Nanopharmaceuticals Sales Market Share by Countries in 2013
Figure North America Nanopharmaceuticals Sales Market Share by Countries in 2017
Table North America Nanopharmaceuticals Revenue by Countries (2013-2018)
Table North America Nanopharmaceuticals Revenue Market Share by Countries (2013-2018)
Figure North America Nanopharmaceuticals Revenue Market Share by Countries in 2013
Figure North America Nanopharmaceuticals Revenue Market Share by Countries in 2017
Figure United States Nanopharmaceuticals Sales and Growth Rate (2013-2018)
Figure Canada Nanopharmaceuticals Sales and Growth Rate (2013-2018)
Figure Mexico Nanopharmaceuticals Sales and Growth Rate (2013-2018)
Figure Europe Nanopharmaceuticals Revenue and Growth Rate (2013-2018)
Table Europe Nanopharmaceuticals Sales by Countries (2013-2018)
Table Europe Nanopharmaceuticals Sales Market Share by Countries (2013-2018)
Table Europe Nanopharmaceuticals Revenue by Countries (2013-2018)
Figure Europe Nanopharmaceuticals Revenue Market Share by Countries in 2016
Figure Europe Nanopharmaceuticals Revenue Market Share by Countries in 2017
Figure Germany Nanopharmaceuticals Sales and Growth Rate (2013-2018)
Figure UK Nanopharmaceuticals Sales and Growth Rate (2013-2018)
Figure France Nanopharmaceuticals Sales and Growth Rate (2013-2018)
Figure Russia Nanopharmaceuticals Sales and Growth Rate (2013-2018)
Figure Italy Nanopharmaceuticals Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Nanopharmaceuticals Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Nanopharmaceuticals Sales by Countries (2013-2018)
Table Asia-Pacific Nanopharmaceuticals Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Nanopharmaceuticals Sales Market Share by Countries 2017
Table Asia-Pacific Nanopharmaceuticals Revenue by Countries (2013-2018)
Figure Asia-Pacific Nanopharmaceuticals Revenue Market Share by Countries 2017
Figure China Nanopharmaceuticals Sales and Growth Rate (2013-2018)
Figure Japan Nanopharmaceuticals Sales and Growth Rate (2013-2018)
Figure Korea Nanopharmaceuticals Sales and Growth Rate (2013-2018)
Figure India Nanopharmaceuticals Sales and Growth Rate (2013-2018)
Figure Southeast Asia Nanopharmaceuticals Sales and Growth Rate (2013-2018)
Figure South America Nanopharmaceuticals Revenue and Growth Rate (2013-2018)
Table South America Nanopharmaceuticals Sales by Countries (2013-2018)
Table South America Nanopharmaceuticals Sales Market Share by Countries (2013-2018)
Figure South America Nanopharmaceuticals Sales Market Share by Countries in 2017
Table South America Nanopharmaceuticals Revenue by Countries (2013-2018)
Table South America Nanopharmaceuticals Revenue Market Share by Countries (2013-2018)
Figure South America Nanopharmaceuticals Revenue Market Share by Countries in 2017
Figure Brazil Nanopharmaceuticals Sales and Growth Rate (2013-2018)
Figure Argentina Nanopharmaceuticals Sales and Growth Rate (2013-2018)
Figure Colombia Nanopharmaceuticals Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Nanopharmaceuticals Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Nanopharmaceuticals Sales by Countries (2013-2018)
Table Middle East and Africa Nanopharmaceuticals Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Nanopharmaceuticals Sales Market Share by Countries in 2017
Table Middle East and Africa Nanopharmaceuticals Revenue by Countries (2013-2018)
Table Middle East and Africa Nanopharmaceuticals Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Nanopharmaceuticals Revenue Market Share by Countries in 2013
Figure Middle East and Africa Nanopharmaceuticals Revenue Market Share by Countries in 2017
Figure Saudi Arabia Nanopharmaceuticals Sales and Growth Rate (2013-2018)
Figure UAE Nanopharmaceuticals Sales and Growth Rate (2013-2018)
Figure Egypt Nanopharmaceuticals Sales and Growth Rate (2013-2018)
Figure Nigeria Nanopharmaceuticals Sales and Growth Rate (2013-2018)
Figure South Africa Nanopharmaceuticals Sales and Growth Rate (2013-2018)
Table Global Nanopharmaceuticals Sales by Type (2013-2018)
Table Global Nanopharmaceuticals Sales Share by Type (2013-2018)
Table Global Nanopharmaceuticals Revenue by Type (2013-2018)
Table Global Nanopharmaceuticals Revenue Share by Type (2013-2018)
Figure Global Liposomes Sales Growth (2013-2018)
Figure Global Liposomes Price (2013-2018)
Figure Global Polymeric Micelles Sales Growth (2013-2018)
Figure Global Polymeric Micelles Price (2013-2018)
Figure Global Solid Lipid Nanoparticles Sales Growth (2013-2018)
Figure Global Solid Lipid Nanoparticles Price (2013-2018)
Figure Global Microemulsion and Nnanoemulsion Sales Growth (2013-2018)
Figure Global Microemulsion and Nnanoemulsion Price (2013-2018)
Figure Global Nanosuspension Sales Growth (2013-2018)
Figure Global Nanosuspension Price (2013-2018)
Table Global Nanopharmaceuticals Sales by Application (2013-2018)
Table Global Nanopharmaceuticals Sales Share by Application (2013-2018)
Figure Global Autoimmune Disorders Sales Growth (2013-2018)
Figure Global Inflammation Sales Growth (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Nanopharmaceuticals Sales, Revenue and Growth Rate (2018-2023)
Table Global Nanopharmaceuticals Sales Forecast by Regions (2018-2023)
Table Global Nanopharmaceuticals Market Share Forecast by Regions (2018-2023)
Figure North America Sales Nanopharmaceuticals Market Forecast (2018-2023)
Figure Europe Sales Nanopharmaceuticals Market Forecast (2018-2023)
Figure Asia-Pacific Sales Nanopharmaceuticals Market Forecast (2018-2023)
Figure South America Sales Nanopharmaceuticals Market Forecast (2018-2023)
Figure Middle East and Africa Sales Nanopharmaceuticals Market Forecast (2018-2023)
Table Global Nanopharmaceuticals Sales Forecast by Type (2018-2023)
Table Global Nanopharmaceuticals Market Share Forecast by Type (2018-2023)
Table Global Nanopharmaceuticals Sales Forecast by Application (2018-2023)
Table Global Nanopharmaceuticals Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List


【レポートのキーワード】

ナノ医薬品、リポソーム、高分子ミセル、固体脂質ナノ粒子、マイクロエマルションおよびナノエマルジョン、ナノ懸濁液、がんおよび腫瘍、自己免疫疾患、炎症、その他

★調査レポート[ナノ医薬品の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)] (コード:GIR8104398)販売に関する免責事項を必ずご確認ください。
★調査レポート[ナノ医薬品の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆